KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Debt Ratio (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Debt Ratio for 8 consecutive years, with 0.52 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt Ratio fell 26.48% year-over-year to 0.52, compared with a TTM value of 0.52 through Sep 2025, down 26.48%, and an annual FY2024 reading of 0.71, up 12.1% over the prior year.
  • Debt Ratio was 0.52 for Q3 2025 at Biocryst Pharmaceuticals, down from 0.73 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.73 in Q1 2025 and bottomed at 0.46 in Q1 2023.
  • Average Debt Ratio over 3 years is 0.63, with a median of 0.67 recorded in 2023.
  • The sharpest move saw Debt Ratio soared 56.73% in 2024, then decreased 26.48% in 2025.
  • Year by year, Debt Ratio stood at 0.63 in 2023, then increased by 12.1% to 0.71 in 2024, then dropped by 26.65% to 0.52 in 2025.
  • Business Quant data shows Debt Ratio for BCRX at 0.52 in Q3 2025, 0.73 in Q1 2025, and 0.71 in Q4 2024.